Literature DB >> 15235959

The echocardiographic assessment of left ventricular performance during sevoflurane and halothane anesthesia.

H Kasuda1, S Akazawa, R Shimizu.   

Abstract

The cardiovascular effects of sevoflurane were studied and compared with those of halothane in 30 healthy patients. The patients were assigned to receive 1 MAC sevoflurane (n = 10), 2 MAC sevoflurane (n = 10) or 1 MAC halothane (n = 10) in N(2)O 2 l.min(-1) and O(2) 4 l.min(-1). The changes in left ventricular diastolic and systolic dimension (Dd and Ds), fractional shortening (FS), mean velocity of circumferential fiber shortening (mVcf), left ventricular diastolic and systolic volume (Vd and Vs), stroke volume (SV), ejection fraction (EF) and cardiac index (CI) were evaluated by echocardiography. Sevoflurane produced significant dose-dependent decreases in FS, mVcf, EF and SV, but no significant changes in Dd and Vd. Therefore, the decrease in SV was due mainly to the increase in left ventricular residual volume (Vs). One MAC halothane produced a more significant decrease in FS, mVcf, EF and SV, when compared to values obtained at 1 MAC sevoflourane ( P < 0.01). CI was more significantly decreased with 1 MAC halothane than with 1 MAC and 2 MAC sevoflurane ( P < 0.01). This was brought about by a slight decrease in HR with halothane and a slight increase in HR with sevoflurane, in addition to a smaller decrease in SV with sevoflurane than with halothane. This study suggests that sevoflurane may better preserve cardiac function as a pump in healthy patients, when compared to halothane.

Entities:  

Year:  1990        PMID: 15235959     DOI: 10.1007/s0054000040295

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  18 in total

1.  The comparative cardiovascular effects of sevoflurane with halothane and isoflurane.

Authors:  T Kazama; K Ikeda
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

2.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

Authors:  L E Teichholz; T Kreulen; M V Herman; R Gorlin
Journal:  Am J Cardiol       Date:  1976-01       Impact factor: 2.778

3.  The cardiovascular effects of a new inhalation anesthetic, Forane, in human volunteers at constant arterial carbon dioxide tension.

Authors:  W C Stevens; T H Cromwell; M J Halsey; E I Eger; T F Shakespeare; S H Bahlman
Journal:  Anesthesiology       Date:  1971-07       Impact factor: 7.892

4.  Cardiovascular effects of halothane in man.

Authors:  E I Eger; N T Smith; R K Stoelting; D J Cullen; L B Kadis; C E Whitcher
Journal:  Anesthesiology       Date:  1970-05       Impact factor: 7.892

5.  Echocardiographic analysis of human left ventricular diastolic volume and cardiac performance during halothane anesthesia.

Authors:  J I Gerson; C G Gianaris
Journal:  Anesth Analg       Date:  1979 Jan-Feb       Impact factor: 5.108

6.  Ventricular function in children during halothane anesthesia: an echocardiographic evaluation.

Authors:  P G Barash; S Glanz; J D Katz; K Taunt; N S Talner
Journal:  Anesthesiology       Date:  1978-08       Impact factor: 7.892

7.  Echocardiographic assessment of ventricular performance following induction with two anesthetics.

Authors:  R Rathod; H K Jacobs; N E Kramer; L K Rao; M R Salem; W D Towne
Journal:  Anesthesiology       Date:  1978-08       Impact factor: 7.892

8.  Sevoflurane: a new inhalational anesthetic agent.

Authors:  R F Wallin; B M Regan; M D Napoli; I J Stern
Journal:  Anesth Analg       Date:  1975 Nov-Dec       Impact factor: 5.108

9.  Halothane depresses baroreflex control of heart rate in man.

Authors:  P C Duke; D Fownes; J G Wade
Journal:  Anesthesiology       Date:  1977-03       Impact factor: 7.892

10.  The hemodynamic and cardiovascular effects of isoflurane and halothane anesthesia in children.

Authors:  W J Wolf; M B Neal; M D Peterson
Journal:  Anesthesiology       Date:  1986-03       Impact factor: 7.892

View more
  5 in total

1.  Anesthetic management for a patient with oculocerebrorenal (Lowe's) syndrome.

Authors:  Hisao Komatsu; Masatomo Sakakibara; Yutaka Yoshimura; Hiroyuki Kinoshita; Satoshi Yokono; Kenji Ogli
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

2.  Use of sevoflurane inhalation sedation for outpatient third molar surgery.

Authors:  S Ganzberg; J Weaver; F M Beck; G McCaffrey
Journal:  Anesth Prog       Date:  1999

3.  The effects of isoflurane and sevoflurane on the left ventricular end-systolic pressure-volume relation in dogs.

Authors:  Sumio Hoka; Michiko Sato; Shosuke Takahashi
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

4.  Sevoflurane anesthesia maintains reflex tachycardia on position change from supine recumbent to head-up tilt.

Authors:  Hitoshi Adachi
Journal:  J Anesth       Date:  1996-06       Impact factor: 2.078

Review 5.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.